You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 7 No. 4, Jul-Aug 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Facial Plastic Surgery
 •Cosmetic Surgery/ Procedures
 •Alert me on articles by topic

Injected Hyaluronidase Reduces Restylane-Mediated Cutaneous Augmentation

A. John Vartanian, MD; Andrew S. Frankel, MD; Mark G. Rubin, MD

Arch Facial Plast Surg. 2005;7:231-237.

Objective  To determine the effects of injected hyaluronidase in cutaneous areas previously augmented with Restylane (Q-Med AB, Uppsala, Sweden), a nonanimal, stabilized hyaluronic acid (NASHA) gel.

Methods  A prospective, randomized study was undertaken in 2 parts. First, the effects of hyaluronidase and saline were compared on post-NASHA dermal augmentation. Next, 3 different doses of hyaluronidase were evaluated after NASHA gel dermal augmentation. A blinded evaluator assigned postinjection skin scores. Each patient served as his or her own control.

Results  Hyaluronidase dramatically reduced the size of the augmentation created by injected Restylane in all of our subjects. A comparison of average scores of saline-injected sites vs hyaluronidase-injected sites revealed a statistically significant difference. By 4 to 7 days after hyaluronidase injection, skin scores were at 20% of baseline (P<.001). Dose-related response to injected hyaluronidase was also observed, although it was not statistically significant. A number of patients (25%) demonstrated localized, self-limiting hypersensitivity reactions to injected hyaluronidase.

Conclusions  Intradermal hyaluronidase injections can be used to reduce dermal augmentation from previously injected Restylane. A small dose of hyaluronidase equivalent to 5 to 10 U may be injected initially.


Author Affiliations: Department of Otolaryngology–Head and Neck Surgery, University of Southern California, Los Angeles (Dr Vartanian); Department of Surgery, Division of Head and Neck Surgery, University of California, Los Angeles, UCLA School of Medicine (Drs Vartanian and Frankel); and Lasky Clinic (Dr Frankel) and Lasky Skin Clinic (Dr Rubin), Beverly Hills, Calif.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hyaluronidase and Restylane
Soparkar et al.
Arch Facial Plast Surg 2007;9:299-300.
FULL TEXT  

Hyaluronidase for Fixing Restylane Mistakes
Journal Watch Dermatology 2005;2005:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.